These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 20360850)

  • 1. Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity.
    Slominski AT; Janjetovic Z; Fuller BE; Zmijewski MA; Tuckey RC; Nguyen MN; Sweatman T; Li W; Zjawiony J; Miller D; Chen TC; Lozanski G; Holick MF
    PLoS One; 2010 Mar; 5(3):e9907. PubMed ID: 20360850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1).
    Guryev O; Carvalho RA; Usanov S; Gilep A; Estabrook RW
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14754-9. PubMed ID: 14657394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450scc-dependent metabolism of 7-dehydrocholesterol in placenta and epidermal keratinocytes.
    Slominski AT; Kim TK; Chen J; Nguyen MN; Li W; Yates CR; Sweatman T; Janjetovic Z; Tuckey RC
    Int J Biochem Cell Biol; 2012 Nov; 44(11):2003-18. PubMed ID: 22877869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation.
    Zbytek B; Janjetovic Z; Tuckey RC; Zmijewski MA; Sweatman TW; Jones E; Nguyen MN; Slominski AT
    J Invest Dermatol; 2008 Sep; 128(9):2271-80. PubMed ID: 18368131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of 22-hydroxy metabolites of vitamin d3 by cytochrome p450scc (CYP11A1) and analysis of their biological activities on skin cells.
    Tuckey RC; Li W; Shehabi HZ; Janjetovic Z; Nguyen MN; Kim TK; Chen J; Howell DE; Benson HA; Sweatman T; Baldisseri DM; Slominski A
    Drug Metab Dispos; 2011 Sep; 39(9):1577-88. PubMed ID: 21677063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical synthesis of 20S-hydroxyvitamin D3, which shows antiproliferative activity.
    Li W; Chen J; Janjetovic Z; Kim TK; Sweatman T; Lu Y; Zjawiony J; Tuckey RC; Miller D; Slominski A
    Steroids; 2010 Dec; 75(12):926-35. PubMed ID: 20542050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential metabolism of 7-dehydrocholesterol to steroidal 5,7-dienes in adrenal glands and its biological implication in the skin.
    Slominski AT; Zmijewski MA; Semak I; Sweatman T; Janjetovic Z; Li W; Zjawiony JK; Tuckey RC
    PLoS One; 2009; 4(2):e4309. PubMed ID: 19190754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions.
    Slominski AT; Kim TK; Li W; Yi AK; Postlethwaite A; Tuckey RC
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():28-39. PubMed ID: 24176765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum and pig adrenal gland.
    Slominski AT; Kim TK; Li W; Postlethwaite A; Tieu EW; Tang EKY; Tuckey RC
    Sci Rep; 2015 Oct; 5():14875. PubMed ID: 26445902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
    Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
    Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
    Jung SJ; Lee YY; Pakkala S; de Vos S; Elstner E; Norman AW; Green J; Uskokovic M; Koeffler HP
    Leuk Res; 1994 Jun; 18(6):453-63. PubMed ID: 8207963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.
    Hisatake J; Kubota T; Hisatake Y; Uskokovic M; Tomoyasu S; Koeffler HP
    Cancer Res; 1999 Aug; 59(16):4023-9. PubMed ID: 10463602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways and products for the metabolism of vitamin D3 by cytochrome P450scc.
    Tuckey RC; Li W; Zjawiony JK; Zmijewski MA; Nguyen MN; Sweatman T; Miller D; Slominski A
    FEBS J; 2008 May; 275(10):2585-96. PubMed ID: 18410379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential antitumor effects of vitamin D analogues on colorectal carcinoma in culture.
    Wierzbicka JM; Binek A; Ahrends T; Nowacka JD; Szydłowska A; Turczyk Ł; Wąsiewicz T; Wierzbicki PM; Sądej R; Tuckey RC; Slominski AT; Chybicki J; Adrych K; Kmieć Z; Żmijewski MA
    Int J Oncol; 2015 Sep; 47(3):1084-96. PubMed ID: 26260259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photoprotective Properties of Vitamin D and Lumisterol Hydroxyderivatives.
    Slominski AT; Chaiprasongsuk A; Janjetovic Z; Kim TK; Stefan J; Slominski RM; Hanumanthu VS; Raman C; Qayyum S; Song Y; Song Y; Panich U; Crossman DK; Athar M; Holick MF; Jetten AM; Zmijewski MA; Zmijewski J; Tuckey RC
    Cell Biochem Biophys; 2020 Jun; 78(2):165-180. PubMed ID: 32441029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective ability of rat 7-Dehydrocholesterol reductase (DHCR7) to act on some 7-Dehydrocholesterol metabolites but not on lumisterol metabolites.
    Tuckey RC; Tang EKY; Chen YA; Slominski AT
    J Steroid Biochem Mol Biol; 2021 Sep; 212():105929. PubMed ID: 34098080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of 1alpha-hydroxyvitamin D3 by cytochrome P450scc to biologically active 1alpha,20-dihydroxyvitamin D3.
    Tuckey RC; Janjetovic Z; Li W; Nguyen MN; Zmijewski MA; Zjawiony J; Slominski A
    J Steroid Biochem Mol Biol; 2008 Dec; 112(4-5):213-9. PubMed ID: 19000766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin.
    Slominski A; Zjawiony J; Wortsman J; Semak I; Stewart J; Pisarchik A; Sweatman T; Marcos J; Dunbar C; C Tuckey R
    Eur J Biochem; 2004 Nov; 271(21):4178-88. PubMed ID: 15511223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
    Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.